Search:

Home Federal Initiatives Request Meeting

Home About Us Announcements Recent Announcements January 2008 : February 2008 : March 2008 : April 2008 : May 2008 : June 2008 June 2008 Guidance for Industry: Providing Regulatory Submissions in Electronic Format - Postmarketing Individual Case Safety Reports Public Workshop: Blood Establishment Computer Software Blood Products Advisory Committee: Charter Guidance for Industry: Indexing Structured Product Labeling Experimental Infection of Cattle with Highly Pathogenic Avian Influenza Virus (H5N1) D. Kalthoff et al. Back to Top May 2008 2008 PHEMCE Stakeholders Workshop (September 24 – September 26, 2008) Physical and Biological Dosimetry Techniques and Devices Useful in Initial Triage after Radiologic and Nuclear Events Back to Top April 2008 Advanced Development of Next Generation Portable Ventilators Back to Top March 2008 RFQ-BARDA-08-19: Contract Research Organization for Immunogenicity Studies SS-HHS-BARDA-08-99: Emergency Responder Anthrax Antimicrobial Kits RFQ-BARDA-08-17: Contract Research Organization for Toxicology Studies Back to Top February 2008 BAA-BARDA-08-08: Therapies for Hematopoietic Syndrome, Bone Marrow Stromal Cell Loss and Vascular Injury Resulting From Acute Exposure to Ionizing Radiation NOT-RR-08-004: Notice of Cancellation of the Center of Biomedical Research Excellence Program Announcement CDC: Shipping Instructions for Specimens Collected from People Who May have been Exposed to Chemical-Terrorism Agents RFP-BARDA-08-15: recombinant Protective Antigen (rPA) Anthrax Vaccine for the Strategic National Stockpile RFA-AI-08-014: Cooperative Centers for Translational Research on Human Immunology and Biodefense RFA-AI-08-001: Cooperative Research Partnerships for Biodefense and Emerging Infectious Diseases Notice from CDC to Vaccine Holders to Destroy Dryvax Vaccine CDC Pandemic Influenza Funding Announcement for Competitive Proposals FAQ Pandemic Influenza Funding Announcement for Competitive Proposals: 1 of 2 FAQ Pandemic Influenza Funding Announcement for Competitive Proposals: 2 of 2 RFA-AI-08-001: Cooperative Research Partnerships for Biodefense and Emerging Infectious Diseases Draft Guidance for Industry and FDA Staff: Establishing the Performance Characteristics of In Vitro Diagnostic Devices for the Detection or Detection and Differentiation of Influenza Viruses RFP-BARDA-08-15: recombinant Protective Antigen (rPA) Anthrax Vaccine for the Strategic National Stockpile HHS-BARDA-08-01-SB: recombinant Protective Antigen (rPA) Anthrax Vaccine for the Strategic National Stockpile (Synopsis) SS-DHHS-BARDA-07-01: Anthrax recombinant Protective Antigen (rPA) vaccine for the Strategic National Stockpile (SNS) (Amendment 01) Vaccines and Related Biological Products Advisory Committee (February 20-21, 2008) Back to Top January 2008 RFP-BARDA-08-12: Medkits National Science Advisory Board for Biosecurity (Day 1) National Science Advisory Board for Biosecurity (Day 2) $24M of CDC funding for IT for pandemic flu preparedness RFA-AI-08-002 Regional Centers of Excellence for Biodefense and Emerging Infectious Diseases Research (RCE) Program “Medicine in the Media” Course (May 5-7) Emergency Preparedness and Biodefense (February 26, 2008) Burn Care (January 29, 2008: Videocast) BARDA/NIAID Medical Countermeasures to Mitigate and/or Treat Ionizing Radiation-Induced Pulmonary Injury: Project Bioshield (RC1) Back to Top Website Disclaimers | USA.gov | No Fear Act | Accessibility | Privacy Policy | White House | FOIA This is an official U.S. Government Web site managed by the U.S. Department of Health & Human Services. Contact Webmaster